Prot #AST-008-102: A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab in Patients with Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date4/6/20 → 4/6/26

Funding

  • MS Clinical Services, LLC (Prot #AST-008-102)
  • Exicure, Inc. (Prot #AST-008-102)